Cloves Syndrome
📧 Sign up to get email alerts when something new happens for Cloves Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lymphatic Anomalies Registry for the Assessment of Outcome Data
The ClinicalTrials.gov study NCT02399527 at Boston Children's Hospital is a recruiting registry to collect outcome data on lymphatic anomali…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS clinical trial (NCT05563831) has completed, providing an update on patients with PIK3CA-related overgrowth spectrum and related con…
-
CLINICAL_TRIALS safety_alert · 2026-02-19Clinical Trial Update: Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery [NA]
A clinical trial update indicates ongoing safety evaluation of the Sonablate HIFU System for ablation of incompetent peripheral veins; the s…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation [Phase 2]
Phase 2 clinical trial update for RLY-2608, a mutant-selective PI3Kα inhibitor, in adults and children with PIK3CA-related overgrowth spectr…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome [Phase 3]
Phase 3 study to evaluate the efficacy and safety of KP-001 versus placebo in patients aged 2 years and older with venous malformations, lym…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.